Yu. I. Moskalev, Remote Consequences of Ionizing Radiations
(Meditsina, Moscow, 1991) [in Russian].Google Scholar
Yu. I. Moskalev and V. N. Strel’tsova, Radiation Carcinogenesis in the Problem of Radiation Protection
(Energoatomizdat, Moscow, 1982) [in Russian].Google Scholar
United Nation Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), Radiation Carcinogenesis in Humans (New York, 1977).
V. N. Strel’tsova and Yu. I. Moskalev, Blastomogenic Effect of Ionizing Radiation
(Meditsina, Moscow, 1964) [in Russian].Google Scholar
A. A. Yarilin, The Action of Ionizing Radiation on Lymphocytes (Damaging and Activating Effects),” Immunologiya, No. 5, 5 (1988).
N. M. Berezhnaya and V. F. Chekhun, The Immunology of Malignant Growth
(Naukova Dumka, Kiev, 2005) [in Russian].Google Scholar
A. M. Unni, T. Bondar, and R. Medzhitov, “Intrinsic Sensor of Oncogenic Transformation Induces a Signal for Innate Immunosurveillance,” Proc. Natl. Acad. Sci. USA 105
, 1686 (2008).ADSCrossRefGoogle Scholar
R. V. Petrov and I. V. Oradovskaya, “Clinical Prelaboratory Diagnostics of the Immune Deficiency in the System of Mass Immunological Examinations of Population, in Proceedings of the All-Union Conference on Methodology, Organization, and Results of Mass Immunological Examinations, Moscow-Angarsk, 1987, p. 215.
R. V. Petrov, R. M. Khaitov, and I. V. Oradovskaya, “Immunological Monitoring of Large Population Groups of the Country,” Immunologiya, No. 4, 43 (1992).
R. V. Petrov, R. M. Khaitov, B. V. Pinegin, and I. V. Oradovskaya, “Estimation of the Immune Status in Mass Examinations: Methodological Recommendations for Researchers and Physicians, Immunologiya, No. 6, 51 (1992).
The State of Oncological Assistance to the Population of Russia in 2005. http://www.oncology.ru/service/sta-tistics/condition/2005
M. I. Davydov and E. M. Aksel’, “Morbidity for Malignant Neoplasms in the Population of Russia and CIS Countries in 2006,” Vestn. RONTs im. N.N. Blokhina RAMN, 19
(2), 52 (2008).Google Scholar
E. M. Aksel’, M. I. Davydov, and T. I. Ushakova, “Malignant Neoplasms of the Gastrointestinal Tract: Main Statistical Characteristics and Trends,” Sovr. Onkologiya 3
(4), 141 (2001).Google Scholar
M. I. Davydov and M. D. Ter-Ovanesov, “Modern Strategy for Surgical Treatment of Gastric Cancer,” Sovr. Onkologiya 2
(1), 4 (2000).Google Scholar
Malignant Neoplasms in St. Petersburg in 1996 (Morbidity, Mortality, Lethality, and Survival Rate), Ed. by V. M. Merabishvili (St. Petersburg, 1999) [in Russian].
Malignant Neoplasms in Russia in 2001, Ed. by V. I. Chissov et al. (Moscow, 2003) [in Russian].
G. A. Zubovskii and S. A. Khrisanfov, “Lung Cancer in people Exposed to Radiation as a Result of Chernobyl Nuclear Accident,” Vopr. Onkologii 49
(3), 359 (2003).Google Scholar
L. P. Kindzel’skii and E. A. Demina, “Analysis of Morbidity in the Liquidators of Chernobyl Accident Consequences,” Vrach. Delo, No. 1, 7 (1998).
V. K. Ivanov, E. M. Rastopchin, A. I. Gorskii, and V. B. Ryvkin, “Oncological Morbidity among the Participants of Chernobyl Accident Cleanup,” Risk i Radiatsiya, No. 8, 65 (1996).
E. Ya. Sosnovskaya, in Health State of the Republic of Belarus Population that Suffered from the Chernobyl Nuclear Accident (Gomel, 2006), pp. 58–69.
N. B. Kholodova, E. B. Shirokova, and L. A. Zhavoronkova, “Premature Aging is Observed at a Remote Date after Small Dose Irradiation,” Vestn. Ross. Voen. Med. Akademii, No. 3, 481 (2008).
N. N. Kazakova, A. A. Savchenko, M. V. Yatsinov, et al., “Specific Features in the Immune Status Depending on the Stage of Gastric Cancer,” Med. Immunologiya 11
(4–5), 429 (2009).Google Scholar
E. M. Aksel’ and B. P. Matveev, The State of Oncourological Diseases in Russia (Moscow, 1999) [in Russia].
V. P. Lazutka, Descriptive Epidemiology, Prophylactic Examinations, and Diagnostics of Early Prostate Cancer Stages in the Lithuanian SSR, Extended Abstract of Candidate’s Dissertation in Medical Sciences (Vilnius, 1987).
V. I. Chissov, V. V. Starinskii, and G. V. Petrova, Malignant Neoplasms in Russia in 2002 (Morbidity and Mortality) (Moscow, 2004) [in Russian].
V. I. Chissov, V. V. Starinskii, and G. V. Petrova, Malignant Neoplasms in Russia in 2006 (Morbidity and Mortality) (Moscow, 2008) [in Russian].
S. L. Parker, T. Tong, S. Bolden, et al., “Cancer Statistics, 1996,” CA Cancer. J. Clin. 65
, 5 (1995).Google Scholar
H. Kato, “Cancer Mortality,” in Cancer in Atomic Bomb Survivors (Tokyo, New York, 1986), pp. 53–74.
V. K. Ivanov, E. V. Nilova, V. A. Efendiev, et al., “Oncoepidemiological Situation in the Kaluga Oblast of Russian Federation Ten Years after Chernobyl Catastrophe,” Vopr. Onkologii, 43
(2), 143 (1997).Google Scholar
S. A. Khrisanfov, “Analysis of the Health State of the Participants of Emergency Cleanup after Chernobyl Nuclear Accident According to the Results of Work of the Russian Interagency Expert Council in 1999,” Vopr. Onkologii 46
(6), 645 (2000).Google Scholar
M. R. Thomas, P. Steinberg, M. L. Votaw, and N. K. Bayne, “IgE Levels in Hodgkin’s Disease,” Ann. Allergy 37
(6), 416, (1976).Google Scholar
R. Hällgren, H. Arrendal, K. Hiesche, et al., “Elevated Serum Immunoglobulin E in Bronchial Carcinoma: Its Relation to the Histology and Prognosis of the Cancer,” J. Allergy Clin. Immunol. 67
(5), 398 (1981).CrossRefGoogle Scholar
E. Jensen-Jarolim, G. Achatz, M. C. Turner, et al., “AllergoOncology: the Role of IgE-Mediated Allergy in Cancer,” Allergy 63
(10), 1255 (2008).CrossRefGoogle Scholar
M. Van Hemelrijck, H. Garmo, E. Binda, et al., “Immunoglobulin E and Cancer: A Meta-Analysis and a Large Swedish Cohort Study,” Cancer Causes Control 21
(10), 1657 (2010).CrossRefGoogle Scholar
D. Goodale, C. Phay, W. Brown, et al., “Flow Cytometric Assessment of Monocyte Activation Markers and Circulating Endothelial Cells in Patients with Localized or Metastatic Breast Cancer,” Cytometry B Clin. Cytom. 76
(2), 107 (2009).Google Scholar
Holland-Frei Cancer Medicine
, Ed. by D. W. Kufe, R. E. Pollock, R. R. Weichselbaum, et al., (BC Decker, 2003). http://www.ncbi.nlm.nih.gov/book-shelf/br.fcgibook=cmed6&part=A308388*
T. Arai, T. Kuroishi, Y. Saito, Y. Kurita, et al., “Tumor Doubling Time and Prognosis in Lung Cancer Patients: Evaluation from Chest Films and Clinical Followup Study. Japanese Lung Cancer Screening Research Group,” Jpn. J. Clin. Oncol. 24
(4), 199 (1994).Google Scholar
M. Akiyama, “Late Effects of Radiation on the Human Immune System: An Overview of Immune Response among the Atomic-Bomb Survivors,” Int. J. Radiat. Biol. 68
(5), 497 (1995).CrossRefGoogle Scholar
Y. Kusunoki and T. Hayashi, “Long-lasting Alterations of the Immune System by Ionizing Radiation Exposure: Implications for Disease Development among Atomic Bomb Survivors,” Int. J. Radiat. Biol. 84
(1), 1 (2008).CrossRefGoogle Scholar